Literature DB >> 21529835

Race disparities in Wilms tumor incidence and biology.

Jason Axt1, Andrew J Murphy, Erin H Seeley, Colin A Martin, Chase Taylor, Janene Pierce, Richard M Caprioli, Martin Whiteside, Harold N Lovvorn.   

Abstract

BACKGROUND: Wilms tumor (WT) is thought to arise in children of Black African ancestry with greater frequency than in Whites. To clarify the biological basis for race disparities in WT, we first verified that Black children residing in Tennessee have an increased incidence of WT, and second, established molecular profiles in WT that are specific to race.
MATERIALS AND METHODS: To assess race disparities in WT epidemiology, the Tennessee Cancer Registry (TCR) was queried for all in-state patients less than 20 y of age and registered between 1999 and 2008. To explore race disparities in WT biology, six Black and four White WT specimens acquired in Tennessee were analyzed using imaging mass spectrometry (IMS).
RESULTS: TCR data show that Black children are over-represented among WT patients (29%) relative to all other childhood cancers (18.5%; P = 0.01). WT ranked the fifth most common cancer diagnosis among Blacks, but ninth among Whites. The diagnosis of WT occurred 79% more frequently among Blacks (n = 28) than Whites (n = 69; P = 0.01), and proportionally more Blacks tended to present with distant disease. Although overall survival from WT was not statistically different between Blacks (92.9%) and Whites (94.0%), Black males showed the lowest survival (85%; P = 0.21). IMS analysis identified peptide spectra from both WT blastema and stroma that independently classify specimens according to race with greater than 80% accuracy.
CONCLUSIONS: In Tennessee, Black children appear more susceptible than Whites to develop WT. Race-specific molecular profiles can be determined that may help to clarify pathways of Wilms tumorigenesis and the biological basis for race disparities in WT incidence and biology.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21529835      PMCID: PMC3150230          DOI: 10.1016/j.jss.2011.03.011

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  24 in total

1.  Frequent association of beta-catenin and WT1 mutations in Wilms tumors.

Authors:  S Maiti; R Alam; C I Amos; V Huff
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

2.  Ethnic variation in the incidence, diagnosis, prognosis, and follow-up of children with Wilms' tumor.

Authors:  N Breslow; A Olshan; J B Beckwith; J Moksness; P Feigl; D Green
Journal:  J Natl Cancer Inst       Date:  1994-01-05       Impact factor: 13.506

3.  Racial variation in incidence of Wilms' tumor: relationship to congenital anomalies.

Authors:  S Kramer; A T Meadows; P Jarrett
Journal:  Med Pediatr Oncol       Date:  1984

4.  Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.

Authors:  Masayuki Takahashi; Ximing J Yang; Todd T Lavery; Kyle A Furge; Bart O Williams; Maria Tretiakova; Anthony Montag; Nicholas J Vogelzang; Gian G Re; A Julian Garvin; Stefan Söderhäll; Susumu Kagawa; Debra Hazel-Martin; Agneta Nordenskjold; Bin Tean Teh
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

5.  Challenges and outcome of Wilms' tumour management in a resource-constrained setting.

Authors:  J C H Wilde; W Lameris; E H van Hasselt; E M Molyneux; H A Heij; E G Borgstein
Journal:  Afr J Paediatr Surg       Date:  2010 Sep-Dec

Review 6.  Epidemiology of Wilms tumor.

Authors:  N Breslow; A Olshan; J B Beckwith; D M Green
Journal:  Med Pediatr Oncol       Date:  1993

7.  Incidence of childhood cancer: experience of a decade in a population-based registry.

Authors:  S Kramer; A T Meadows; P Jarrett; A E Evans
Journal:  J Natl Cancer Inst       Date:  1983-01       Impact factor: 13.506

8.  Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.

Authors:  R G Grundy; J Pritchard; P Scambler; J K Cowell
Journal:  Oncogene       Date:  1998-07-23       Impact factor: 9.867

9.  Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition.

Authors:  Chi-Ming Li; Meirong Guo; Alain Borczuk; Charles A Powell; Michelle Wei; Harshwardhan M Thaker; Richard Friedman; Ulf Klein; Benjamin Tycko
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

10.  International variations in the incidence of childhood renal tumours.

Authors:  C A Stiller; D M Parkin
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

View more
  14 in total

1.  Wilms tumor survival in Kenya.

Authors:  Jason Axt; Fatmah Abdallah; Meridith Axt; Jessie Githanga; Erik Hansen; Joel Lessan; Ming Li; Joyce Musimbi; Michael Mwachiro; Mark Newton; James Ndung'u; Festis Njuguna; Ancent Nzioka; Oliver Oruko; Kirtika Patel; Robert Tenge; Flora Ukoli; Russel White; James A O'Neill; Harold N Lovvorn
Journal:  J Pediatr Surg       Date:  2013-06       Impact factor: 2.545

Review 2.  Label-free molecular imaging of the kidney.

Authors:  Boone M Prentice; Richard M Caprioli; Vincent Vuiblet
Journal:  Kidney Int       Date:  2017-07-24       Impact factor: 10.612

3.  Molecular characterization of Wilms' tumor from a resource-constrained region of sub-Saharan Africa.

Authors:  Andrew J Murphy; Jason R Axt; Christian de Caestecker; Janene Pierce; Hernan Correa; Erin H Seeley; Richard M Caprioli; Mark W Newton; Mark P de Caestecker; Harold N Lovvorn
Journal:  Int J Cancer       Date:  2012-04-04       Impact factor: 7.396

4.  Peptide spectra in Wilms tumor that associate with adverse outcomes.

Authors:  Andrew Jackson Murphy; Janene Pierce; Erin H Seeley; Lisa M Sullivan; Eduardo D Ruchelli; Michael L Nance; Richard M Caprioli; Harold N Lovvorn
Journal:  J Surg Res       Date:  2015-03-18       Impact factor: 2.192

5.  Neurocognitive outcomes in long-term survivors of Wilms tumor: a report from the St. Jude Lifetime Cohort.

Authors:  Ingrid Tonning Olsson; Tara M Brinkman; Geehong Hyun; Pia Banerjee; Daniel A Mulrooney; I-Chan Huang; Daniel M Green; Deokumar Srivastava; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  J Cancer Surviv       Date:  2019-06-26       Impact factor: 4.442

6.  Race disparities in peptide profiles of North American and Kenyan Wilms tumor specimens.

Authors:  Jaime M Libes; Erin H Seeley; Ming Li; Jason R Axt; Janene Pierce; Hernan Correa; Mark Newton; Erik Hansen; Audra Judd; Hayes McDonald; Richard M Caprioli; Arlene Naranjo; Vicki Huff; James A O'Neill; Harold N Lovvorn
Journal:  J Am Coll Surg       Date:  2014-01-24       Impact factor: 6.113

7.  Race, ethnicity, and socioeconomic differences in incidence of pediatric embryonal tumors in the United States.

Authors:  Jennifer M Geris; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2020-07-16       Impact factor: 3.167

Review 8.  Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research.

Authors:  Jeremy L Norris; Richard M Caprioli
Journal:  Chem Rev       Date:  2013-02-11       Impact factor: 60.622

9.  Prostate cancer health disparities: An immuno-biological perspective.

Authors:  Sanjay Kumar; Rajesh Singh; Shalie Malik; Upender Manne; Manoj Mishra
Journal:  Cancer Lett       Date:  2017-11-15       Impact factor: 8.679

Review 10.  Nephroblastoma--a 25-year review of a South African unit.

Authors:  Y T Visser; R Uys; A van Zyl; D C Stefan
Journal:  J Med Life       Date:  2014-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.